title: [Adjuvant medical treatment].
abstract: Adjuvant medical treatments (chemotherapy or endocrine therapy) are now used in the vast majority of women with breast cancer. They delay recurrences and reduce their number, the increase in survival being particularly marked in limited forms. They also reinforce local treatment and increase the possibility of breast conservation. Their indications can be better determined by precise analysis of prognostic factors, notably tumoral cells.
authors.affiliation: Service d'oncologie médicale, centre Jean-Perrin, Clermont-Ferrand.
authors.forename: R
authors.initials: R
authors.lastname: Plagne
authors.forename: P
authors.initials: P
authors.lastname: Chollet
authors.forename: M
authors.initials: M
authors.lastname: Legros
authors.forename: H
authors.initials: H
authors.lastname: Cure
authors.forename: J P
authors.initials: JP
authors.lastname: Ferrière
authors.forename: Y J
authors.initials: YJ
authors.lastname: Bignon
mesh_terms: D000277:Adjuvants, Pharmaceutic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D010052:Ovariectomy; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D000277:Adjuvants, Pharmaceutic; D013629:Tamoxifen
vernacular_title: Les traitements médicaux adjuvants.